Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01549600 · ClinicalTrials.gov registry record · NA
Comparison of Psyllium and Microcrystalline Cellulose on Glycemic Measures in Subjects With Impaired Fasting Glucose
A NA study of Impaired Fasting Glucose, sponsored by Procter and Gamble.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT01549600: Completed NA study of Impaired Fasting Glucose, sponsored by Procter and Gamble.
NCT01549600 is a NA study of Impaired Fasting Glucose that has completed, run by Procter and Gamble. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01549600, a NA study of Impaired Fasting Glucose, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
The Purpose of this study is to compare the effects of 2 types of dietary fiber, psyllium and microcrystalline cellulose (MCC), on glycemic measures in subjects with impaired fasting glucose.
Primary Outcome
mean change from baseline in fasting serum glucose at 8 weeks
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Microcrystalline Cellulose
- DIETARY_SUPPLEMENT psyllium
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2012-02 |
| Est. Completion | 2013-05 |
| Phase | NA |
What the finished NCT01549600 record still lists
NCT01549600 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Impaired Fasting Glucose appearing as the primary indexed condition, and to 2 interventions - of which Microcrystalline Cellulose is the first listed.
NCT01549600 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT01549600 about?
NCT01549600 is a clinical study titled "Comparison of Psyllium and Microcrystalline Cellulose on Glycemic Measures in Subjects With Impaired Fasting Glucose". The Purpose of this study is to compare the effects of 2 types of dietary fiber, psyllium and microcrystalline cellulose (MCC), on glycemic measures in subjects with impaired fasting glucose.
What is the current status of trial NCT01549600?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2012-02. Estimated completion is 2013-05.
What conditions does trial NCT01549600 study?
This clinical trial studies the following conditions: Impaired Fasting Glucose.
What interventions are being tested in trial NCT01549600?
The interventions under investigation include: Microcrystalline Cellulose (DIETARY_SUPPLEMENT), psyllium (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01549600?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01549600 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Impaired Fasting Glucose
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01549600's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia